Noacid (Pantoprazole Sodium Sesquihydrate)

Pantoprazole, the active ingredient in Noacid, is a proton pump inhibitor presented as an oral formulation for oral use. It reduces gastric acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease, erosive oesophagitis, Zollinger‑Ellison syndrome, and NSAID‑induced gastric ulcers in adult patients.

GNH USA supplies Noacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows strict quality standards and consistently provides reliable global distribution for this prescription‑only medication.

Pantoprazole is a proton pump inhibitor that reduces gastric acid secretion in several acid‑related conditions.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn, regurgitation and esophageal irritation by maintaining a higher gastric pH and promoting mucosal healing. - Erosive oesophagitis: facilitates healing of inflamed esophageal tissue and prevents further damage by suppressing acid exposure. - Zollinger‑Ellison syndrome: controls excessive gastric acid output caused by gastrin‑producing tumors, reducing ulcer formation. - NSAID‑induced gastric ulcer: protects the gastric lining and supports ulcer healing in patients using non‑steroidal anti‑inflammatory drugs.

Adverse reactions may occur with pantoprazole therapy.

Common Side Effects: - Headache: mild to moderate pain often occurring early in treatment. - Diarrhea: loose stools that may resolve with continued use. - Nausea: feeling of queasiness, sometimes accompanied by abdominal discomfort. - Abdominal pain: cramping or discomfort in the stomach region. - Flatulence: increased gas production leading to bloating.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reaction: rash, swelling, or anaphylaxis requiring immediate medical attention. - Low magnesium (hypomagnesemia): muscle cramps, irregular heartbeat, or seizures. - Liver enzyme elevation: abnormal liver function tests indicating possible hepatic stress. - Bone fracture risk: increased susceptibility to fractures with long‑term use.

Patients and prescribers should consider several safety measures when using Noacid.

- Renal or hepatic impairment: assess function and adjust therapy as needed. - Elderly patients: monitor for increased sensitivity to side effects. - Magnesium levels: check periodically, especially during prolonged treatment. - Discontinuation: avoid abrupt cessation after long‑term use to prevent rebound acid hypersecretion. - Drug interactions: review concomitant medications for potential effects on acid suppression. - Store below 25°C: keep in the original pack, protect from moisture and light.

Pantoprazole may affect the absorption or metabolism of other medicines.

Major Interactions (Avoid): - Ketoconazole: reduced antifungal absorption due to decreased gastric acidity. - Atazanavir: impaired antiviral efficacy caused by increased gastric pH. - Clopidogrel: decreased antiplatelet activity leading to reduced cardiovascular protection.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of anticoagulant effect, requiring INR monitoring. - Digoxin: modest increase in serum levels, necessitating periodic assessment. - Methotrexate: enhanced toxicity risk, especially at high doses, requiring dose adjustment.